Federated Hermes, Inc. Amphastar Pharmaceuticals, Inc. Call Options Transaction History
Federated Hermes, Inc.
- $41.2 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AMPH
# of Institutions
280Shares Held
34.8MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$304 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$137 Million0.0% of portfolio
-
Td Asset Management Inc1.69MShares$86.5 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$83 Million0.05% of portfolio
-
State Street Corp Boston, MA1.53MShares$78.2 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.51B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...